Bayesian Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,207	Closed	-$477K	–	1083
2023 Q2	$477K	Buy	+13,207	New	+$477K	0.05%	419
2022 Q3	–	Sell	-16,493	Closed	-$1.11M	–	1082
2022 Q2	$1.11M	Buy	+16,493	New	+$1.11M	0.21%	131